Cytosorbents (CTSO) Announces Positive Data from REFRESH I Trial; Primary Safety Endpoint Met
Go back to Cytosorbents (CTSO) Announces Positive Data from REFRESH I Trial; Primary Safety Endpoint MetCytosorbents Corporation (NASDAQ: CTSO) | Delayed: 0.81 -0.01 (1.22%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.82 | 52 Week High | $7.48 | |||
Open | $0.83 | 52 Week Low | $3.11 | |||
Day High | $0.86 | P/E | N/A | |||
Day Low | $0.80 | EPS | $-0.03 | |||
Volume | 46,377 |